IDSA releases guidance on treatment of antimicrobial-resistant infections.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Subject Terms:
      UNITED States
    • Abstract:
      The article provides information about new guidance from the Infectious Diseases Society of America (IDSA) that offers clinical treatment advice for drug-resistant infections caused by three common Gram-negative bacteria groups: Extended-spectrum β-lactamase producing Enterobacterales (ESBL-E), Carbapenem-resistant Enterobacterales (CRE), and Difficult-to-treat resistance (DTR)-Pseudomonas aeruginosa.